Electroacupuncture at Body acupoints and Fenglong (ST 40) for regulating serum lipids in dyslipidemic patients
Phase 3
Completed
- Conditions
- Dyslipidemiaacupuncture therapydyslipidemia
- Registration Number
- TCTR20131003001
- Lead Sponsor
- Faculty of Medicine, SW
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Patients who were diagnosed with dyslipidemia (defined as triglycerides ≥ 150 mg/dL, or total cholesterol (TC) ≥ 200 mg/dL or HDL-cholesterol (HDL-C) < 40 mg/dL (men) or HDL-C < 50 mg/dL (women) or LDL-cholesterol (LDL-C) > 130 mg/dL) and were not taking any lipid-lowering drugs were invited to participate in the study.
Exclusion Criteria
Patients who had a history of bleeding disorders or were receiving anticoagulant or anti-platelet aggregation medications, had epilepsy, uncontrolled hypertension, and active dermatological lesions at the area of acupuncture, as well as pregnant women or those patients whose mental disabilities made their participation in the study difficult were excluded from the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method an improvement in serum lipid levels at the end of treatment percentage of improvement
- Secondary Outcome Measures
Name Time Method sustained improvement during the follow-up period 4 weeks at the end of treatment serum lipids